Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease.

Farhan KhanZiyad AllehebiYahya ShabiIan DavisJason LeBlancRobbin LindsayTodd F Hatchette

Published in: Open forum infectious diseases (2022)

The modified 2-tier testing algorithm (MTTT) for Lyme disease (LD) has been approved by the US Food and Drug Administration. In this study, we show that the MTTT detected 28% more cases of early infection compared with the standard 2-tier algorithm while retaining high specificity in a region with a high incidence of LD.

Keyphrases

drug administration
machine learning
deep learning
neural network
risk factors
sars cov
human health
coronavirus disease
structural basis
label free